Researchers sought to determine whether long-term ropeginterferon alfa-2b would have benefits in patients with PV compared with hydroxyurea or the best available treatment.
Researchers sought to find whether there was a relationship between patient-reported outcomes and overall survival after hematopoietic stem cell transplantation.
Researchers sought to determine whether varicella-zoster virus vaccination with a recombinant vaccine would show results in patients who underwent HSCT.
The approval was based on data demonstrating a high degree of similarity of Fylnetra to the reference product, with no clinically meaningful differences.
The final 6 months of life is presumed to be a high-risk period for depression and anxiety in patients with cancer. However, few studies have examined whether depression and anxiety do occur in the last year of life and to what extent.
A study sought to determine the impact of infection, gastrointestinal, bone/muscle, and metabolic/endocrine complications in patients receiving steroids for GVHD on HCRU and costs.
Researchers assessed the characteristics and distribution of hepatitis C virus (HCV) genotypes among individuals with confirmed HCV infection who donated blood during a 16-year period.
Having a high blood tumor mutational burden was associated with a significant improvement in response and a trend toward improvement in survival outcomes.
Researchers sought to determine whether adding MSC to basiliximab and a calcineurin inhibitor would improve outcomes in patients with aGVHD after HSCT.
Researchers sought to classify health-promoting behavior levels among family caregivers of patients with cancer and to identify risk factors for low levels.
Pediatric cancer patients in low- and middle-income countries had a nearly 16-fold higher risk of all-cause mortality within 30 days of presentation, when compared with their counterparts in high-income countries.
Researchers conducted a retrospective study comparing the incidence of second malignancy in cancer patients treated with genetically modified immune effector cells with those who received unmodified cells.
Roughly half of patients with hematologic cancers or solid tumors lost neutralizing antibody responses to SARS-CoV-2 variants of concern at 6 months after vaccination.
Researchers sought to determine whether iron supplementation would improve quality of life and functional capacity of patients with cancer who develop iron deficiency.